Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
    • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Jan 16, 2018Jan 19, 2018Hansen John David
Pres
CEO
SellMabvax Therapeutics Holdings, Inc.MBVX$0.92$54,522-9.94%
Jan 10, 2018Jan 16, 2018Hansen John David
Pres
CEO
SellMabvax Therapeutics Holdings, Inc.MBVX$0.97$186,263-24.43%
May 19, 2017Aug 02, 2017Hansen John David
Pres
CEO
BuyMabvax Therapeutics Holdings, Inc.MBVX$0.82$7,501+11.45%
Apr 12, 2017Apr 14, 2017Hansen John David
Pres
CEO
SellMabvax Therapeutics Holdings, Inc.MBVX$2$20,433-14.25%
Apr 07, 2017Apr 11, 2017Hansen John David
Pres
CEO
SellMabvax Therapeutics Holdings, Inc.MBVX$2$2,955-2.02%
Apr 04, 2017Apr 06, 2017Hansen John David
Pres
CEO
SellMabvax Therapeutics Holdings, Inc.MBVX$2.17$10,969-6.46%
Aug 17, 2016Aug 19, 2016Hansen John David
Pres
CEO
BuyMabvax Therapeutics Holdings, Inc.MBVX~$0+7.67%